Cargando…

Plasma hepatocyte growth factor as a noninvasive biomarker in small cell lung cancer

BACKGROUND: Hepatocyte growth factor (HGF) is a peptide-containing multifunctional cytokine, which is overexpressed and/or activated in multiple malignancies and is reported to be associated with tumor development and inferior survival. At present, the role of HGF in small cell lung cancer (SCLC) ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Cong, Tong, Li, Liu, Bin, Qi, Fei, Zhang, Zhiyun, Guo, Yi, Liu, Yanxia, Wang, Ying, Zhang, Lina, Lu, Baohua, Li, Baolan, Zhang, Tongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568809/ https://www.ncbi.nlm.nih.gov/pubmed/37828456 http://dx.doi.org/10.1186/s12885-023-10995-z

Ejemplares similares

A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice
por: Liu, Yanxia, et al.
Publicado: (2022)

Hyaluronic Acid Correlates With Bone Metastasis and Predicts Poor Prognosis in Small-Cell Lung Cancer Patients
por: Zhao, Cong, et al.
Publicado: (2022)

Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer
por: Wang, Ying, et al.
Publicado: (2023)

Topoisomerase I expression is associated with prognosis in postoperative non‐small cell lung cancer patients
por: Lu, Baohua, et al.
Publicado: (2016)

Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer
por: Wang, Ying, et al.
Publicado: (2019)

Survival Analysis of 159 Patients With Advanced Non-Small-Cell Lung Cancer Resistant to First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
por: Hu, Aimin, et al.
Publicado: (2023)

Beneficial effects of postoperative radiotherapy for IIIA‑N2 non‑small cell lung cancer after radical resection analysed using the propensity score‑matching method
por: Tian, Cuimeng, et al.
Publicado: (2023)

Role of aneuploid circulating tumor cells and CD31(+) circulating tumor endothelial cells in predicting and monitoring anti‐angiogenic therapy efficacy in advanced NSCLC
por: Zhang, Tongmei, et al.
Publicado: (2021)

Trichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature review
por: Zheng, Hua, et al.
Publicado: (2016)

Plasma MicroRNAs as Potential Noninvasive Biomarkers for In-Stent Restenosis
por: He, Meijiao, et al.
Publicado: (2014)

Postoperative Radiotherapy for Patients with Completely Resected Pathological Stage IIIA-N2 Non-small Cell Lung Cancer: A Preferential Benefit for Squamous Cell Carcinoma
por: Tian, Cuimeng, et al.
Publicado: (2020)

Investigating the mechanism by which SMAD3 induces PAX6 transcription to promote the development of non-small cell lung cancer
por: Qian, Zhe, et al.
Publicado: (2018)

Mutation status analysis of 58 patients with advanced ALK fusion gene positive non small cell lung cancer
por: Yang, Yuan, et al.
Publicado: (2023)

Comprehensive Comparative Molecular Characterization of Young and Old Lung Cancer Patients
por: Hu, Mingming, et al.
Publicado: (2022)

Plasma Methylated RNF180 for Noninvasive Diagnosis of Gastric Cancer
por: Zhao, Luyao, et al.
Publicado: (2022)

Plasma-Methylated SEPT9 for the Noninvasive Diagnosis of Gastric Cancer
por: Zhao, Luyao, et al.
Publicado: (2022)

The relationship between the preoperative plasma level of HIF-1α and clinic pathological features, prognosis in non-small cell lung cancer
por: He, Jiabei, et al.
Publicado: (2016)

Clinical verification of plasma messenger RNA as novel noninvasive biomarker identified through bioinformatics analysis for lung cancer
por: Zhou, Dan, et al.
Publicado: (2017)

Detection of epidermal growth factor receptor mutation in plasma as a biomarker in Chinese patients with early-stage non-small cell lung cancer
por: Guo, Kai, et al.
Publicado: (2015)

Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis
por: Caussy, Cyrielle, et al.
Publicado: (2020)

Plasma MicroRNAs as noninvasive diagnostic biomarkers in patients with Brugada syndrome
por: Ikeuchi, Yoshihiro, et al.
Publicado: (2022)

Urinary exosome proteins PAK6 and EGFR as noninvasive diagnostic biomarkers of diabetic nephropathy
por: Li, Tao, et al.
Publicado: (2023)

The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition
por: Zhang, Kun, et al.
Publicado: (2019)

Ultrasonographic optic nerve sheath diameter as a noninvasive marker for intracranial hypotension
por: Wang, Li-juan, et al.
Publicado: (2022)

Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution
por: Cheng, Xi, et al.
Publicado: (2021)

Application and development of noninvasive biomarkers for colorectal cancer screening: a systematic review
por: Song, Dan, et al.
Publicado: (2023)

A proteomics approach to the identification of plasma biomarkers for latent tuberculosis infection
por: Zhang, Xia, et al.
Publicado: (2014)

Peripheral Blood Leukocyte N6-methyladenosine is a Noninvasive Biomarker for Non-small-cell Lung Carcinoma
por: Pei, Yuqing, et al.
Publicado: (2020)

Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer
por: Han, Yueting, et al.
Publicado: (2021)

The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer
por: Feng, Yu, et al.
Publicado: (2022)

SEPT9 Gene Methylation as a Noninvasive Marker for Hepatocellular Carcinoma
por: Li, Baoliang, et al.
Publicado: (2020)

Identification of a Plasma Four-microRNA Panel as Potential Noninvasive Biomarker for Osteosarcoma
por: Lian, Feng, et al.
Publicado: (2015)

A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma
por: Liu, Xiao-Xia, et al.
Publicado: (2019)

Plasma circulating cell‐free MYCN gene: A noninvasive and prominent recurrence monitoring indicator of neuroblastoma
por: Liang, Ying, et al.
Publicado: (2022)

Hepatocyte growth factor and soluble cMet levels in plasma are prognostic biomarkers of mortality in patients with severe acute kidney injury
por: Li, Lilin, et al.
Publicado: (2021)

Plasma lipid profiling and diagnostic biomarkers for oral squamous cell carcinoma
por: Wang, Lina, et al.
Publicado: (2017)

miRNAs from Plasma Extracellular Vesicles Are Signatory Noninvasive Prognostic Biomarkers against Atherosclerosis in LDLr(−/−)Mice
por: Zhai, Ke-feng, et al.
Publicado: (2022)

Urinary Biomarkers for the Noninvasive Detection of Gastric Cancer
por: Li, Dehong, et al.
Publicado: (2022)

Predictive Value of a Noninvasive Serological Hepatic Fibrosis Scoring System in Cirrhosis Combined with Oesophageal Varices
por: Zhang, Feiyue, et al.
Publicado: (2018)

Gastric cancer‐associated long non‐coding RNA profiling and noninvasive biomarker screening based on a high‐risk population cohort
por: Guo, Xiaoying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hvpvprjfhnb090q9flin06nppj